Trial Profile
A Double-Blind, Placebo-Controlled, Randomized, Single Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-42165279 in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Jul 2017
Price :
$35
*
At a glance
- Drugs JNJ 42165279 (Primary)
- Indications Anxiety disorders
- Focus Adverse reactions; Biomarker; Pharmacokinetics
- 17 Jun 2013 New trial record